Sfoglia per Autore
cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer?
2013 Milano, Annalisa; D'Antonio, Chiara; Lombardini, Alberto; Durante, Valeria; Romiti, Adriana; Sarcina, Ida; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo
clinicAl outcomes in pAtients with colorectAl cAncer And liver metAstAses: “the times they Are A-chAnging”
2013 Romiti, A; Milano, Annalisa; Balducci, G; Ferri, M; Roberto, Michela; D’Antonio, C; Durante, V; Mazzuca, F; Marchetti, P; Ziparo, V.
PD-0001CAN WE PREDICT TIME TO TUMOR PROGRESSION IN EARLY COLORECTAL CANCER PATIENTS USING CTCS COUNT?
2013 Roberto, M.; Romiti, Adriana; Di Rocco, R.; Raffa, S.; Ranieri, Danilo; Milano, Annalisa; Durante, V.; D'Antonio, C.; Torrisi, Maria Rosaria; Marchetti, Paolo
Resistance to abiraterone in castration-resistant prostate cancer: a review of the literature.
2014 S., Giacinti; M., Bassanelli; A. M., Aschelter; Milano, Annalisa; Roberto, Michela; Marchetti, Paolo
Circulating tumor cells count predicts survival in colorectal cancer patients.
2014 Romiti, Adriana; Raffa, Salvatore; R., Di Rocco; Roberto, Michela; Milano, Annalisa; A., Zullo; Leone, Laura; Ranieri, Danilo; F., Mazzetta; E., Medda; I., Sarcina; Barucca, Viola; C., D'Antonio; V., Durante; Ferri, Mario; Torrisi, Maria Rosaria; Marchetti, Paolo
A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer
2015 Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; D'Antonio, Chiara; Milano, Annalisa; Falcone, Rosa; Barucca, Viola; Palombi, Lucia; Righini, Riccardo; Marchetti, Paolo
Continuous, low-dose capecitabine for patients with recurrent colorectal cancer
2015 Romiti, Adriana; Onesti, Concetta Elisa; Roberto, Michela; Barucca, Viola; Tomao, Silverio; D’Antonio, Chiara; Durante, Valeria; Milano, Annalisa; Falcone, Rosa; Di Rocco, Roberta; Righini, Riccardo; Marchetti, Paolo
Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure
2015 Onesti, CONCETTA ELISA; Romiti, Adriana; Roberto, Michela; Falcone, Rosa; Marchetti, Paolo
Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study
2015 Milano, Annalisa; D'Antonio, Chiara; Roberto, Michela; Falcone, Rosa; DI PIETRO, FRANCESCA ROMANA; Durante, Valeria; Romiti, Adriana; Marchetti, P.
Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma
2015 Roberto, Michela; Bassanelli, Maria; Iannicelli, Elsa; Giacinti, Silvana; D'Antonio, Chiara; Aschelter, Anna Maria; Marchetti, Paolo
F295-fluorouracil degradation rate (5-FU-DR) could predict toxicity in breast cancer patients treated with capecitabine
2016 Onesti, C. E.; Botticelli, A.; Mazzuca, F.; Angelini, S.; Petremolo, A.; Falcone, R.; Roberto, M.; Occhipinti, M.; Romiti, A.; Lionetto, L.; Simmaco, M.; Marchetti, P.
Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy
2016 Bassanelli, Maria; Viterbo, Antonella; Roberto, Michela; Giacinti, Silvana; Staddon, Anita; Aschelter, Anna Maria; D'Antonio, Chiara; Marchetti, Paolo
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer
2016 Romiti, Adriana; Roberto, Michela; D'Antonio, Chiara; Onesti, CONCETTA ELISA; Barucca, Viola; Milano, Annalisa; Gentile, Giovanna; Lionetto, Luana; Medda, Emanuela; Mazzuca, Federica; Botticelli, Andrea; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art
2016 Falcone, Rosa; Roberto, Michela; D'Antonio, Chiara; Romiti, Adriana; Milano, Annalisa; Onesti, CONCETTA ELISA; Marchetti, Paolo; Fais, Stefano
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX
2016 Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica
Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial
2016 Marchetti, Paolo; Milano, Annalisa; D'Antonio, Chiara; Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Fais, Stefano
Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis
2016 Romiti, Adriana; Rulli, Eliana; Pilozzi, Emanuela; Gerardi, Chiara; Roberto, Michela; Legramandi, Lorenzo; Falcone, Rosa; Pacchetti, Ilaria; Marchetti, Paolo; Floriani, Irene
Evolving treatments for advanced gastric cancer: appraisal of the survival trend
2016 Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; Zullo, Angelo; Falcone, Rosa; Marchetti, Paolo
The role of stereotactic body radiation therapy in oligometastatic colorectal cancer
2017 Roberto, Michela; Falcone, Rosa; Mazzuca, Federica; Archibugi, Livia; Castaldi, Nadia; Botticelli, Andrea; Osti, Mattia Falchetto; Marchetti, Paolo
Duration of response to first androgen deprivation therapy, time to castration resistance prostate cancer, and outcome of metastatic castration resistance prostate cancer patients treated with abiraterone acetate
2017 Giacinti, Silvana; Carlini, Paolo; Roberto, Michela; Bassanelli, Maria; Strigari, Lidia; Pavese, Francesco; Aschelter, Anna M.; Felici, Alessandra; Valeriani, Maurizio; Cognetti, Francesco; Marchetti, Paolo
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer? | 2013 | Milano, Annalisa; D'Antonio, Chiara; Lombardini, Alberto; Durante, Valeria; Romiti, Adriana; Sarcina, Ida; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo | |
clinicAl outcomes in pAtients with colorectAl cAncer And liver metAstAses: “the times they Are A-chAnging” | 2013 | Romiti, A; Milano, Annalisa; Balducci, G; Ferri, M; Roberto, Michela; D’Antonio, C; Durante, V; Mazzuca, F; Marchetti, P; Ziparo, V. | |
PD-0001CAN WE PREDICT TIME TO TUMOR PROGRESSION IN EARLY COLORECTAL CANCER PATIENTS USING CTCS COUNT? | 2013 | Roberto, M.; Romiti, Adriana; Di Rocco, R.; Raffa, S.; Ranieri, Danilo; Milano, Annalisa; Durante, V.; D'Antonio, C.; Torrisi, Maria Rosaria; Marchetti, Paolo | |
Resistance to abiraterone in castration-resistant prostate cancer: a review of the literature. | 2014 | S., Giacinti; M., Bassanelli; A. M., Aschelter; Milano, Annalisa; Roberto, Michela; Marchetti, Paolo | |
Circulating tumor cells count predicts survival in colorectal cancer patients. | 2014 | Romiti, Adriana; Raffa, Salvatore; R., Di Rocco; Roberto, Michela; Milano, Annalisa; A., Zullo; Leone, Laura; Ranieri, Danilo; F., Mazzetta; E., Medda; I., Sarcina; Barucca, Viola; C., D'Antonio; V., Durante; Ferri, Mario; Torrisi, Maria Rosaria; Marchetti, Paolo | |
A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer | 2015 | Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; D'Antonio, Chiara; Milano, Annalisa; Falcone, Rosa; Barucca, Viola; Palombi, Lucia; Righini, Riccardo; Marchetti, Paolo | |
Continuous, low-dose capecitabine for patients with recurrent colorectal cancer | 2015 | Romiti, Adriana; Onesti, Concetta Elisa; Roberto, Michela; Barucca, Viola; Tomao, Silverio; D’Antonio, Chiara; Durante, Valeria; Milano, Annalisa; Falcone, Rosa; Di Rocco, Roberta; Righini, Riccardo; Marchetti, Paolo | |
Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure | 2015 | Onesti, CONCETTA ELISA; Romiti, Adriana; Roberto, Michela; Falcone, Rosa; Marchetti, Paolo | |
Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study | 2015 | Milano, Annalisa; D'Antonio, Chiara; Roberto, Michela; Falcone, Rosa; DI PIETRO, FRANCESCA ROMANA; Durante, Valeria; Romiti, Adriana; Marchetti, P. | |
Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma | 2015 | Roberto, Michela; Bassanelli, Maria; Iannicelli, Elsa; Giacinti, Silvana; D'Antonio, Chiara; Aschelter, Anna Maria; Marchetti, Paolo | |
F295-fluorouracil degradation rate (5-FU-DR) could predict toxicity in breast cancer patients treated with capecitabine | 2016 | Onesti, C. E.; Botticelli, A.; Mazzuca, F.; Angelini, S.; Petremolo, A.; Falcone, R.; Roberto, M.; Occhipinti, M.; Romiti, A.; Lionetto, L.; Simmaco, M.; Marchetti, P. | |
Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy | 2016 | Bassanelli, Maria; Viterbo, Antonella; Roberto, Michela; Giacinti, Silvana; Staddon, Anita; Aschelter, Anna Maria; D'Antonio, Chiara; Marchetti, Paolo | |
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer | 2016 | Romiti, Adriana; Roberto, Michela; D'Antonio, Chiara; Onesti, CONCETTA ELISA; Barucca, Viola; Milano, Annalisa; Gentile, Giovanna; Lionetto, Luana; Medda, Emanuela; Mazzuca, Federica; Botticelli, Andrea; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo | |
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art | 2016 | Falcone, Rosa; Roberto, Michela; D'Antonio, Chiara; Romiti, Adriana; Milano, Annalisa; Onesti, CONCETTA ELISA; Marchetti, Paolo; Fais, Stefano | |
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX | 2016 | Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica | |
Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial | 2016 | Marchetti, Paolo; Milano, Annalisa; D'Antonio, Chiara; Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Fais, Stefano | |
Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis | 2016 | Romiti, Adriana; Rulli, Eliana; Pilozzi, Emanuela; Gerardi, Chiara; Roberto, Michela; Legramandi, Lorenzo; Falcone, Rosa; Pacchetti, Ilaria; Marchetti, Paolo; Floriani, Irene | |
Evolving treatments for advanced gastric cancer: appraisal of the survival trend | 2016 | Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; Zullo, Angelo; Falcone, Rosa; Marchetti, Paolo | |
The role of stereotactic body radiation therapy in oligometastatic colorectal cancer | 2017 | Roberto, Michela; Falcone, Rosa; Mazzuca, Federica; Archibugi, Livia; Castaldi, Nadia; Botticelli, Andrea; Osti, Mattia Falchetto; Marchetti, Paolo | |
Duration of response to first androgen deprivation therapy, time to castration resistance prostate cancer, and outcome of metastatic castration resistance prostate cancer patients treated with abiraterone acetate | 2017 | Giacinti, Silvana; Carlini, Paolo; Roberto, Michela; Bassanelli, Maria; Strigari, Lidia; Pavese, Francesco; Aschelter, Anna M.; Felici, Alessandra; Valeriani, Maurizio; Cognetti, Francesco; Marchetti, Paolo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile